Search details
1.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Article
in English
| MEDLINE | ID: mdl-34914339
2.
Emerging noninvasive methylation biomarkers of cancer prognosis and drug response prediction.
Semin Cancer Biol
; 83: 584-595, 2022 08.
Article
in English
| MEDLINE | ID: mdl-33757849
3.
Explainable clinical coding with in-domain adapted transformers.
J Biomed Inform
; 139: 104323, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36813154
4.
Design and implementation of a standard care programme of therapeutic exercise and education for breast cancer survivors.
Support Care Cancer
; 30(2): 1243-1251, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34463835
5.
High IGKC-Expressing Intratumoral Plasma Cells Predict Response to Immune Checkpoint Blockade.
Int J Mol Sci
; 23(16)2022 Aug 15.
Article
in English
| MEDLINE | ID: mdl-36012390
6.
Development of a Novel NGS Methodology for Ultrasensitive Circulating Tumor DNA Detection as a Tool for Early-Stage Breast Cancer Diagnosis.
Int J Mol Sci
; 24(1)2022 Dec 21.
Article
in English
| MEDLINE | ID: mdl-36613590
7.
Validation of pain catastrophizing scale on breast cancer survivor.
Pain Pract
; 22(8): 711-717, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36136052
8.
Validity and reliability of the Spanish fear-avoidance components scale in breast cancer survivors.
Eur J Cancer Care (Engl)
; 30(6): e13506, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34423870
9.
Structural validity and reliability of the Spanish Central Sensitization Inventory in breast cancer survivors.
Pain Pract
; 21(7): 740-746, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33768652
10.
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.
N Engl J Med
; 375(18): 1738-1748, 2016 11 03.
Article
in English
| MEDLINE | ID: mdl-27717303
11.
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.
Breast Cancer Res Treat
; 177(2): 383-393, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31172407
12.
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study.
Breast Cancer Res Treat
; 177(1): 115-125, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31152327
13.
Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2.
Breast Cancer Res Treat
; 170(3): 535-545, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29654415
14.
Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial.
Breast Cancer Res Treat
; 167(3): 659-669, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29058175
15.
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2- advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
Breast Cancer Res Treat
; 169(3): 469-479, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29404806
16.
Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.
Mod Pathol
; 31(2): 299-306, 2018 02.
Article
in English
| MEDLINE | ID: mdl-28984296
17.
Hereditary breast and ovarian cancer in Andalusian families: a genetic population study.
BMC Cancer
; 18(1): 647, 2018 Jun 08.
Article
in English
| MEDLINE | ID: mdl-29884136
18.
Shallow whole genome sequencing for robust copy number profiling of formalin-fixed paraffin-embedded breast cancers.
Exp Mol Pathol
; 104(3): 161-169, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29608913
19.
Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
BMC Complement Altern Med
; 18(1): 180, 2018 Jun 11.
Article
in English
| MEDLINE | ID: mdl-29890985
20.
High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer.
Oncologist
; 21(2): 150-5, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26786263